Are PCSK9 Inhibitors Cost Effective?

Korman, MJ; Retterstol, K; Kristiansen, IS; Wisloff, T

Wisloff, T (reprint author), Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.; Wisloff, T (reprint author), Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modelling, Oslo, Norway.

PHARMACOECONOMICS, 2018; 36 (9): 1031

Abstract

The objective of this study was to review available health economic evaluations of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. T......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索